Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of Tolbutamide
Status:
Recruiting
Trial end date:
2022-02-21
Target enrollment:
Participant gender:
Summary
This is a Phase 1, 2-period, multiple-dose, open-label, single fixed sequence study of the
effect of ritlecitinib on tolbutamide pharmacokinetics in healthy participants.